arrow
A

Alan H. Fairlamb

university of dundee
H指数:78
被引数:2.7万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Multiple unbiased approaches identify oxidosqualene cyclase as the molecular target of a promising anti-leishmanial

多种无偏方法将氧化鲨烯环化酶鉴定为有希望的抗利什曼原药的分子靶标

2021-05-0114
OAAI
Antikinetoplastid SAR study in 3-nitroimidazopyridine series: Identification of a novel non-genotoxic and potent anti-T.b. brucei hitcompound with improved pharmacokinetic properties
2020-11-0113
OAAI
8-Alkynyl-3-nitroimidazopyridines display potent antitrypanosomal activity against both T. b. brucei and cruzi
2020-09-0116
OAAI
New 8-Nitroquinolinone Derivative Displaying Submicromolar in Vitro Activities against Both Trypanosoma brucei and cruzi
2020-02-0610
OAAI
The Qi Site of Cytochrome b is a Promiscuous Drug Target in Trypanosoma cruzi and Leishmania donovani
2020-01-2224
OAAI
Substituted Aminoacetamides as Novel Leads for Malaria Treatment
2019-07-036
OAAI
Preclinical candidate for the treatment of visceral leishmaniasis that acts through proteasome inhibition
2019-04-08115
OAAI
Lysyl-tRNA synthetase as a drug target in malaria and cryptosporidiosis
2019-03-20111
OAAI
Nongenotoxic 3-Nitroimidazo[1,2-a]pyridines Are NTR1 Substrates That Display Potent in Vitro Antileishmanial Activity
2018-12-1936
OAAI
Pharmacological Validation of N-Myristoyltransferase as a Drug Target in Leishmania donovani
2018-11-0153
OAAI
8-Aryl-6-chloro-3-nitro-2-(phenylsulfonylmethyl)imidazo[1,2-a] pyridines as potent antitrypanosomatid molecules bioactivated by type 1 nitroreductases
2018-09-0116
OAAI